{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T02:57:34Z","timestamp":1781837854876,"version":"3.54.5"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T00:00:00Z","timestamp":1584921600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["104807\/Z\/14\/Z"],"award-info":[{"award-number":["104807\/Z\/14\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008721","name":"University College London Hospitals NHS Foundation Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008721","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["755170-2"],"award-info":[{"award-number":["755170-2"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["SEP-210221188"],"award-info":[{"award-number":["SEP-210221188"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012618","name":"National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012618","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000765","name":"University College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000765","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["40-419000-98-020"],"award-info":[{"award-number":["40-419000-98-020"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003784","name":"Great Ormond Street Hospital for Children","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003784","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.omtm.2020.03.016","type":"journal-article","created":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T19:18:09Z","timestamp":1585682289000},"page":"666-682","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["Successful Preclinical Development of Gene Therapy for Recombinase-Activating Gene-1-Deficient SCID"],"prefix":"10.1016","volume":"17","author":[{"given":"Laura","family":"Garcia-Perez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marja","family":"van Eggermond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieke","family":"van Roon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra A.","family":"Vloemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn","family":"Cordes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Schambach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Rothe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmar","family":"Berghuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Lagresle-Peyrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Cavazzana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian J.","family":"Thrasher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Salvatori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Meij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques J.M.","family":"Van Dongen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaap-Jan","family":"Zwaginga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam","family":"van der Burg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Bobby","family":"Gaspar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjan","family":"Lankester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank J.T.","family":"Staal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Pike-Overzet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2020.03.016_bib1","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/ni0610-457","article-title":"20 years of gene therapy for SCID","volume":"11","author":"Fischer","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.omtm.2020.03.016_bib2","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.jaci.2009.10.022","article-title":"Improving cellular therapy for primary immune deficiency diseases: recognition, diagnosis, and management","volume":"124","author":"Griffith","year":"2009","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.omtm.2020.03.016_bib3","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1001\/jama.295.5.508","article-title":"Bone marrow transplantation for severe combined immune deficiency","volume":"295","author":"Grunebaum","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.omtm.2020.03.016_bib4","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1172\/JCI30953","article-title":"Gene therapy for severe combined immunodeficiency: are we there yet?","volume":"117","author":"Cavazzana-Calvo","year":"2007","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtm.2020.03.016_bib5","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1517\/14712598.5.9.1175","article-title":"Gene therapy for severe combined immunodeficiencies","volume":"5","author":"Gaspar","year":"2005","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.omtm.2020.03.016_bib6","first-page":"2145","article-title":"The immunophenotypic and immunogenotypic B-cell differentiation arrest in bone marrow of RAG-deficient SCID patients corresponds to residual recombination activities of mutated RAG proteins","volume":"100","author":"Noordzij","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2020.03.016_bib7","doi-asserted-by":"crossref","first-page":"467101","DOI":"10.1155\/2012\/467101","article-title":"From murine to human nude\/SCID: the thymus, T-cell development and the missing link","volume":"2012","author":"Romano","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.omtm.2020.03.016_bib8","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jaci.2015.08.022","article-title":"Identification of checkpoints in human T-cell development using severe combined immunodeficiency stem cells","volume":"137","author":"Wiekmeijer","year":"2016","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.omtm.2020.03.016_bib9","first-page":"515","article-title":"Advances in gene therapy for ADA-deficient SCID","volume":"4","author":"Aiuti","year":"2002","journal-title":"Curr. Opin. Mol. Ther."},{"key":"10.1016\/j.omtm.2020.03.016_bib10","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1172\/JCI31666","article-title":"Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapy","volume":"117","author":"Aiuti","year":"2007","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtm.2020.03.016_bib11","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJMoa0805817","article-title":"Gene therapy for immunodeficiency due to adenosine deaminase deficiency","volume":"360","author":"Aiuti","year":"2009","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2020.03.016_bib12","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1081\/NCN-200027508","article-title":"Evaluation of ADA gene expression and transduction efficiency in ADA\/SCID patients undergoing gene therapy","volume":"23","author":"Carlucci","year":"2004","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.omtm.2020.03.016_bib13","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1126\/science.288.5466.669","article-title":"Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease","volume":"288","author":"Cavazzana-Calvo","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.omtm.2020.03.016_bib14","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(04)17590-9","article-title":"Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector","volume":"364","author":"Gaspar","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.omtm.2020.03.016_bib15","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1517\/14712598.8.4.397","article-title":"Gene therapy of inherited immunodeficiencies","volume":"8","author":"Santilli","year":"2008","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.omtm.2020.03.016_bib16","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1126\/science.1088547","article-title":"LMO2-associated clonal T\u00a0cell proliferation in two patients after gene therapy for SCID-X1","volume":"302","author":"Hacein-Bey-Abina","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.omtm.2020.03.016_bib17","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nrc1122","article-title":"Occurrence of leukaemia following gene therapy of X-linked SCID","volume":"3","author":"Kohn","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.omtm.2020.03.016_bib18","doi-asserted-by":"crossref","first-page":"E5","DOI":"10.1038\/nature05218","article-title":"Gene therapy: is IL2RG oncogenic in T-cell development?","volume":"443","author":"Pike-Overzet","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2020.03.016_bib19","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1038\/sj.mt.6300297","article-title":"New insights and unresolved issues regarding insertional mutagenesis in X-linked SCID gene therapy","volume":"15","author":"Pike-Overzet","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.03.016_bib20","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1172\/JCI35798","article-title":"Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients","volume":"118","author":"Howe","year":"2008","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtm.2020.03.016_bib21","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1172\/JCI37630","article-title":"The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy","volume":"119","author":"Montini","year":"2009","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtm.2020.03.016_bib22","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/sj.mt.6300393","article-title":"Self-inactivating gammaretroviral vectors for gene therapy of X-linked severe combined immunodeficiency","volume":"16","author":"Thornhill","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.03.016_bib23","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1038\/mt.2008.118","article-title":"Stable and functional lymphoid reconstitution in Artemis-deficient mice following lentiviral Artemis gene transfer into hematopoietic stem cells","volume":"16","author":"Benjelloun","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.03.016_bib24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1182\/blood-2005-05-2032","article-title":"Long-term immune reconstitution in RAG-1-deficient mice treated by retroviral gene therapy: a balance between efficiency and toxicity","volume":"107","author":"Lagresle-Peyrou","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2020.03.016_bib25","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/sj.mt.6300353","article-title":"Restoration of human B-cell differentiation into NOD-SCID mice engrafted with gene-corrected CD34+ cells isolated from Artemis or RAG1-deficient patients","volume":"16","author":"Lagresle-Peyrou","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.03.016_bib26","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1038\/leu.2011.106","article-title":"Correction of murine Rag1 deficiency by self-inactivating lentiviral vector-mediated gene transfer","volume":"25","author":"Pike-Overzet","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.omtm.2020.03.016_bib27","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.jaci.2013.10.009","article-title":"Recombination-activating gene 1 (Rag1)-deficient mice with severe combined immunodeficiency treated with lentiviral gene therapy demonstrate autoimmune Omenn-like syndrome","volume":"133","author":"van Til","year":"2014","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.omtm.2020.03.016_bib28","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jaci.2014.04.033","article-title":"Successful RAG1-SCID gene therapy depends on the level of RAG1 expression","volume":"134","author":"Pike-Overzet","year":"2014","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.omtm.2020.03.016_bib29","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1089\/hum.2006.17.253","article-title":"Mutagenesis and oncogenesis by chromosomal insertion of gene transfer vectors","volume":"17","author":"Baum","year":"2006","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2020.03.016_bib30","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.1128\/JVI.72.11.8463-8471.1998","article-title":"A third-generation lentivirus vector with a conditional packaging system","volume":"72","author":"Dull","year":"1998","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2020.03.016_bib31","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1182\/blood.V94.10.3349.422k05_3349_3357","article-title":"Improved expression in hematopoietic and lymphoid cells in mice after transplantation of bone marrow transduced with a modified retroviral vector","volume":"94","author":"Halene","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2020.03.016_bib32","doi-asserted-by":"crossref","first-page":"9088","DOI":"10.1128\/JVI.00485-12","article-title":"Safer, silencing-resistant lentiviral vectors: optimization of the ubiquitous chromatin-opening element through elimination of aberrant splicing","volume":"86","author":"Knight","year":"2012","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2020.03.016_bib33","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1084\/jem.20042524","article-title":"New insights on human T\u00a0cell development by quantitative T\u00a0cell receptor gene rearrangement studies and gene expression profiling","volume":"201","author":"Dik","year":"2005","journal-title":"J.\u00a0Exp. Med."},{"issue":"88","key":"10.1016\/j.omtm.2020.03.016_bib34","first-page":"e51543","article-title":"Linear amplification mediated PCR\u2014localization of genetic elements and characterization of unknown flanking DNA","author":"Gabriel","year":"2014","journal-title":"J.\u00a0Vis. Exp."},{"key":"10.1016\/j.omtm.2020.03.016_bib35","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1089\/biores.2014.0008","article-title":"Sustained engraftment of cryopreserved human bone marrow CD34+ cells in young adult NSG mice","volume":"3","author":"Wiekmeijer","year":"2014","journal-title":"Biores. Open Access"},{"key":"10.1016\/j.omtm.2020.03.016_bib36","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jaci.2010.06.015","article-title":"Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better?","volume":"126","author":"Gennery","year":"2010","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.omtm.2020.03.016_bib37","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1182\/blood-2018-03-840702","article-title":"SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery","volume":"132","author":"Haddad","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2020.03.016_bib38","doi-asserted-by":"crossref","first-page":"335ra57","DOI":"10.1126\/scitranslmed.aad8856","article-title":"Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency","volume":"8","author":"De Ravin","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2020.03.016_bib39","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1182\/blood-2014-12-616003","article-title":"Faster T-cell development following gene therapy compared with haploidentical HSCT in the treatment of SCID-X1","volume":"125","author":"Touzot","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2020.03.016_bib40","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1089\/hum.2015.137","article-title":"Gene therapy for X-linked severe combined immunodeficiency: where do we stand?","volume":"27","author":"Cavazzana","year":"2016","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2020.03.016_bib41","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1182\/blood-2006-05-023507","article-title":"Ex\u00a0vivo gene therapy with lentiviral vectors rescues adenosine deaminase (ADA)-deficient mice and corrects their immune and metabolic defects","volume":"108","author":"Mortellaro","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2020.03.016_bib42","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jaci.2017.01.007","article-title":"New frontiers in the therapy of primary immunodeficiency: From gene addition to gene editing","volume":"139","author":"Kohn","year":"2017","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.omtm.2020.03.016_bib43","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1172\/JCI30928","article-title":"A hypomorphic R229Q Rag2 mouse mutant recapitulates human Omenn syndrome","volume":"117","author":"Marrella","year":"2007","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtm.2020.03.016_bib44","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1172\/JCI30513","article-title":"Homeostatically proliferating CD4 T\u00a0cells are involved in the pathogenesis of an Omenn syndrome murine model","volume":"117","author":"Khiong","year":"2007","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtm.2020.03.016_bib45","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1182\/blood-2008-07-165167","article-title":"Leaky severe combined immunodeficiency and aberrant DNA rearrangements due to a hypomorphic RAG1 mutation","volume":"113","author":"Giblin","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2020.03.016_bib46","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1182\/blood-2017-12-820985","article-title":"Hypomorphic Rag1 mutations alter the preimmune repertoire at early stages of lymphoid development","volume":"132","author":"Ott de Bruin","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2020.03.016_bib47","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.omtm.2018.08.002","article-title":"A nontoxic transduction enhancer enables highly efficient lentiviral transduction of primary murine t\u00a0cells and hematopoietic stem cells","volume":"10","author":"Delville","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2020.03.016_bib48","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.bcmd.2011.04.001","article-title":"Cytokines and culture medium have a major impact on human in\u00a0vitro T-cell differentiation","volume":"47","author":"Six","year":"2011","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.omtm.2020.03.016_bib49","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1002\/stem.1145","article-title":"Human T-lymphoid progenitors generated in a feeder-cell-free Delta-like-4 culture system promote T-cell reconstitution in NOD\/SCID\/\u03b3c\u2212\/\u2212 mice","volume":"30","author":"Reimann","year":"2012","journal-title":"Stem Cells"},{"key":"10.1016\/j.omtm.2020.03.016_bib50","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.stem.2017.10.010","article-title":"Hematopoietic stem cell gene therapy: progress and lessons learned","volume":"21","author":"Morgan","year":"2017","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.omtm.2020.03.016_bib51","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1056\/NEJMoa1700554","article-title":"Hematopoietic stem-cell gene therapy for cerebral adrenoleukodystrophy","volume":"377","author":"Eichler","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2020.03.016_bib52","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.1171242","article-title":"Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy","volume":"326","author":"Cartier","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.omtm.2020.03.016_bib53","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nature09328","article-title":"Transfusion independence and HMGA2 activation after gene therapy of human \u03b2-thalassaemia","volume":"467","author":"Cavazzana-Calvo","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2020.03.016_bib54","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3389\/fped.2019.00443","article-title":"Autologous stem-cell-based gene therapy for inherited disorders: state of the art and perspectives","volume":"7","author":"Staal","year":"2019","journal-title":"Front Pediatr."},{"key":"10.1016\/j.omtm.2020.03.016_bib55","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1073\/pnas.90.9.4319","article-title":"The sizes of the CDR3 hypervariable regions of the murine T-cell receptor beta chains vary as a function of the recombined germ-line segments","volume":"90","author":"Pannetier","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2020.03.016_bib56","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1093\/bioinformatics\/btz804","article-title":"ImSpectR: R package to quantify immune repertoire diversity in spectratype and repertoire sequencing data","volume":"36","author":"Cordes","year":"2020","journal-title":"Bioinformatics"},{"key":"10.1016\/j.omtm.2020.03.016_bib57","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","article-title":"Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936","volume":"17","author":"van Dongen","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.omtm.2020.03.016_bib58","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1182\/blood-2005-08-024976","article-title":"Cell-culture assays reveal the importance of retroviral vector design for insertional genotoxicity","volume":"108","author":"Modlich","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2020.03.016_bib59","series-title":"WHO Guidelines on Nonclinical Evaluation of Vaccines. WHO Technical Report Series No. 927 (World Health Organization)","first-page":"31","year":"2005"},{"key":"10.1016\/j.omtm.2020.03.016_bib60","series-title":"Theory and Practice of Histological Techniques","author":"Bancroft","year":"2008"}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050120300462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050120300462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:33:07Z","timestamp":1762421587000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050120300462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":60,"alternative-id":["S2329050120300462"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2020.03.016","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Successful Preclinical Development of Gene Therapy for Recombinase-Activating Gene-1-Deficient SCID","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2020.03.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors.","name":"copyright","label":"Copyright"}]}}